Akeso Placement - Opportunistic Raise, past Deal Record Has Been Mixed but Relative Size Is Small
Akeso Biopharma Inc (9926 HK) is looking to raise around US$200m from its primary placement. Proceeds from the placement will be used for R&D.
468 Views
Energy Medicine. Personal Experience. Impact. Growth in Asia. Ideas
This is an invest-able idea at the private level with long term benefits. Both for the body, and for other ideas as well.Ever since I turned over...
3.8k Views
Can Innovation labs be assessed to pick stocks for your portfolio?
Companies across different industries are building Innovation centers in Singapore, Hong Kong and other cities across Asia and the rest of the...
693 Views
Hutchison Whampoa Restructuring: Next Move for Watson's?
The announced restructuring of Cheung Kong Limited and Hutchison Whampoa Limited has been well received on the HKEx. Hutchison shares have rallied...
385 Views
No more insights